ARO-MMP7 Inhalation Solution

Matrix metalloproteinase-7 inhibitor · Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARO-MMP7 Inhalation Solution, covering 2025-10-15 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]

See pricing